gms | German Medical Science

29. Wissenschaftlicher Kongress der Deutschen Hochdruckliga

Deutsche Hochdruckliga e. V. DHL ® - Deutsche Hypertonie Gesellschaft Deutsches Kompetenzzentrum Bluthochdruck

23. bis 25.11.2005, Berlin

Association of a Functional Polymorphism of CYP4A11 (T8590C) with Hypertension in a Population Based Sample

Meeting Abstract

  • B. Mayer - Universität Schleswig-Holstein, Campus Lübeck (Lübeck, D)
  • W. Lieb - Universität Schleswig-Holstein, Campus Lübeck (Lübeck, D)
  • A. Götz - Universität Schleswig-Holstein, Campus Lübeck (Lübeck, D)
  • I. König - Universität Schleswig-Holstein, Campus Lübeck (Lübeck, D)
  • H. Schunkert - Universität Schleswig-Holstein, Campus Lübeck (Lübeck, D)
  • J. Erdmann - Universität Schleswig-Holstein, Campus Lübeck (Lübeck, D)
  • C. Hengstenberg - Universität Regensburg (Regensburg, D)
  • A. Döring - Institut für Epidemiologie, GSF-Forschungszentrum, Lübeck
  • H.W. Hense - Institut für Epidemiologie und Sozialmedizin, Münster (Münster, D)

Hypertonie 2005. 29. Wissenschaftlicher Kongress der Deutschen Hochdruckliga. Berlin, 23.-25.11.2005. Düsseldorf, Köln: German Medical Science; 2006. Doc05hochP33

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/hoch2005/05hoch033.shtml

Veröffentlicht: 8. August 2006

© 2006 Mayer et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Genetic variants of the arachidonic acid monooxygenase CYP4A11 result in decreased synthesis of 20-hydroxyeicostatetraenoic acid (20-HETE) and experimental hypertension. Moreover in humans, the T8590C polymorphism of CYP4A11 displayed association with arterial hypertension. The aim of the present study was to further investigate this association in a large population-based sample. Therefore, the participants of the echocardiographic sub-study of the third MONICA (MONitoring trends and determinants in CArdiovascular disease) survey (n=1397) were studied by standardized anthropometric, echocardiographic, and biochemical measurements as well as genotyping for CYP4A11 T8590C allele status. Individuals with the CC genotype having higher systolic (CC: 141.4+/-3.17 mmHg vs. CT: 134.2+/-0.97 mmHg and TT: 134.3+/-0.53 mmHg; p=0.03) and diastolic blood pressure levels (CC: 85.4+/-2.06 mmHg vs. CT: 80.3+/-0.63 mmHg and TT: 80.7+/-0.34 mmHg; p=0.02). Accordingly, the odds ratio (adjusted for age, body mass index and gender) of the CC genotype vs. the CT and TT genotype for hypertension was 3.31 (95% confidence interval (CI): 1.38-7.96; p=0.016) in the entire study population with similar trends in men (4.30 (95% CI: 1.08-17.15)) and women (2.93 (95% CI: 0.88-9.84)). Consistent with the renal effects of the gene, no blood pressure independent association between the T8590C polymorphism and echocardiographic parameters of left ventricular function and geometry was found. In conclusion, our data strengthen the association between the T8590C polymorphism of CYP4A11 and hypertension and suggest a recessive mode of inheritance. By contrast, we found no blood pressure independent modulatory effect of CYP4A11 T8590C on cardiac size, structure and function.